INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 102 filers reported holding INSMED INC in Q3 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $156,000 | -99.2% | 15,814 | -99.0% | 0.01% | -96.8% |
| Q1 2016 | $20,060,000 | +352.4% | 1,583,300 | +548.1% | 0.34% | +409.0% |
| Q4 2015 | $4,434,000 | -35.1% | 244,314 | -39.1% | 0.07% | -50.0% |
| Q4 2013 | $6,829,000 | +8.7% | 401,462 | -0.3% | 0.13% | -5.6% |
| Q3 2013 | $6,283,000 | +4.6% | 402,490 | -19.8% | 0.14% | +1.4% |
| Q2 2013 | $6,005,000 | – | 502,016 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,799,225 | $40,519,000 | 16.80% |
| Foresite Capital Management II, LLC | 967,636 | $21,791,000 | 7.25% |
| Palo Alto Investors LP | 7,159,590 | $161,234,000 | 6.90% |
| Asymmetry Capital Management, L.P. | 162,185 | $3,652,000 | 4.57% |
| NEXTHERA CAPITAL LP | 918,523 | $20,685,000 | 3.41% |
| Redmile Group, LLC | 2,166,362 | $48,786,000 | 1.88% |
| Orbimed Advisors | 2,927,891 | $65,936,000 | 0.82% |
| Rock Springs Capital Management LP | 825,000 | $18,579,000 | 0.79% |
| Bellevue Group AG | 334,489 | $7,533,000 | 0.75% |
| EMERALD ADVISERS, LLC | 726,946 | $16,371,000 | 0.66% |